Find the right Medicare plan for 2025 — compare coverage and costs in minutes.

Compare Medicare Plans →
Senior Health MedPageToday.com - medical news for physicians

Big Win for Secukinumab in Polymyalgia Rheumatica

(MedPage Today) -- LONDON -- The interleukin (IL)-17A inhibitor secukinumab (Cosentyx) was clearly effective in treating polymyalgia rheumatica (PMR) in a phase III trial, researchers reported, even as they also published final data from a failed...

Read full article →